The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications
Abstract
In 2003, bortezomib, a first-in-class therapeutic, gained approval from the US Federal Drug Administration for the treatment of relapsed multiple myeloma and mantle cell lymphoma. Approval in the UK, for multiple myeloma, followed in 2006. Bortezomib contains a boronic acid, a functional group that has become increasingly more commonplace within the medicinal chemistry literature. The introduction of this drug has sparked a renewed interest in the investigation of boronic acids as drugs for a wide range of diseases. This review will guide the reader through the most recent developments in this field, by considering in turn, the biological target's amenable to the action of boronic acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Supuran, C. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2467 · Cited by 3,192
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Miyaura, N., Yamada, K., & Suzuki, A. (1979) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)95429-2 · Cited by 2,237
Structural identification of a bacterial quorum-sensing signal containing boron
Chen, X., Schauder, S., Potier, N., Van Dorsselaer, A., Pelczer, I., Bassler, B. L., & Hughson, F. M. (2002) · Nature · doi:10.1038/415545a · Cited by 1,571
Hideshima, T., Richardson, P. G. G., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & Anderson, K. C. (2001) · PubMed · Cited by 1,508
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
A detailed examination of boronic acid–diol complexation
Springsteen, G., & Wang, B. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00489-1 · Cited by 1,461
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,317
The Chemistry of Neutron Capture Therapy
Soloway, A. H., Tjarks, W., Barnum, B. A., Rong, F.-G., Barth, R. F., Codogni, I. M., & Wilson, J. G. (1998) · Chemical Reviews · doi:10.1021/cr941195u · Cited by 1,143
BindingDB (2025) · PubMed · doi:10.7270/q2dr317m · Cited by 843
Yan, J., Springsteen, G., Deeter, S., & Wang, B. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.08.051 · Cited by 747
Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids
Adams, J., Behnke, M., Chen, S., Cruickshank, A. A., Dick, L. R., Grenier, L., Klunder, J. M., Ma, Y.-T., Plamondon, L., & Stein, R. L. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00029-8 · Cited by 685
Boronic acid compounds as potential pharmaceutical agents
Yang, W., Gao, X., & Wang, B. (2003) · Medicinal Research Reviews · doi:10.1002/med.10043 · Cited by 502
Groll, M., Berkers, C. R., Ploegh, H. L., & Ovaa, H. (2006) · Structure · doi:10.1016/j.str.2005.11.019 · Cited by 473
Bortezomib: Proteasome Inhibition as an Effective Anticancer Therapy
Richardson, P. G., Mitsiades, C., Hideshima, T., & Anderson, K. C. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.042905.122625 · Cited by 361
Boron in plants and animals: Is there a role beyond cell‐wall structure?
Goldbach, H. E., & Wimmer, M. A. (2007) · Journal of Plant Nutrition and Soil Science · doi:10.1002/jpln.200625161 · Cited by 349
Zebrafish: A new model on the pharmaceutical catwalk
Langheinrich, U. (2003) · BioEssays · doi:10.1002/bies.10326 · Cited by 332
Design, Synthesis, and Evaluation of Novel Boronic-Chalcone Derivatives as Antitumor Agents
Kumar, S. K., Hager, E., Pettit, C., Gurulingappa, H., Davidson, N. E., & Khan, S. R. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030213+ · Cited by 303
Biosynthesis and attachment of novel bacterial polyketide synthase starter units
(2002) · Natural Product Reports · doi:10.1039/b003939j · Cited by 301
Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer
Denmeade, S. R., Jakobsen, C. M., Janssen, S., Khan, S. R., Garrett, E. S., Lilja, H., Christensen, S. B., & Isaacs, J. T. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.990 · Cited by 285
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Balzarini, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1707 · Cited by 283
Ling, Y. H., Liebes, L., Jiang, J. D., Holland, J. F., Elliott, P. J., Adams, J., Muggia, F. M., & Perez-Soler, R. (2003) · PubMed · Cited by 283
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Dick, L. R., & Fleming, P. E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.008 · Cited by 273
Piva, R., Ruggeri, B., Williams, M., Costa, G., Tamagno, I., Ferrero, D., Giai, V., Coscia, M., Peola, S., Massaia, M., et al. (2008) · Blood · doi:10.1182/blood-2007-07-100651 · Cited by 252
Paramore, A., & Frantz, S. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1159 · Cited by 244
Kitano, S., Koyama, Y., Kataoka, K., Okano, T., & Sakurai, Y. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90073-z · Cited by 229
A Fluorescent Broad-Spectrum Proteasome Inhibitor for Labeling Proteasomes In Vitro and In Vivo
Verdoes, M., Florea, B. I., Menendez-Benito, V., Maynard, C. J., Witte, M. D., van der Linden, W. A., van den Nieuwendijk, A. M. C. H., Hofmann, T., Berkers, C. R., van Leeuwen, F. W. B., et al. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.013 · Cited by 200
Zi, X., Guo, Y., Simoneau, A. R., Hope, C., Xie, J., Holcombe, R. F., & Hoang, B. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0103 · Cited by 196
Yan, J., Fang, H., & Wang, B. (2005) · Medicinal Research Reviews · doi:10.1002/med.20038 · Cited by 185
Bortezomib: A Review of its Use in Patients with Multiple Myeloma
Curran, M. P., & McKeage, K. (2009) · Drugs · doi:10.2165/00003495-200969070-00006 · Cited by 161
Dorsey, B., Iqbal, M., Chatterjee, S., Menta, E., Bernardini, R., Bernareggi, A., Cassarà, P., D'arasmo, G., Ferretti, E., Munari, S. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7010589 · Cited by 143
Biological and Pharmacokinetic Studies with β-Peptides
Seebàch, D., Abele, S., Schreiber, J. V., et al. (1998) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.1998.734 · Cited by 143
Bone, R. F., Shenvi, A. B., Kettner, C. A., & Agard, D. A. (1987) · Biochemistry · doi:10.1021/bi00398a012 · Cited by 142
Ness, S. R., Martin, R., Kindler, A. M., Paetzel, M., Gold, M. H., Jensen, S. E., Jones, J. B., & Strynadka, N. C. J. (2000) · Biochemistry · doi:10.1021/bi992505b · Cited by 133
Nanomolar Inhibitors of AmpC β-Lactamase
Morandi, F., Caselli, E., Morandi, S., Focia, P. J., Blázquez, J., Shoichet, B. K., & Prati, F. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0288338 · Cited by 130
Inhibition of Serine Proteases by Arylboronic Acids
Philipp, M., & Bender, M. L. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.2.478 · Cited by 123
Powers, R. A., Caselli, E., Focia, P. J., Prati, F., & Shoichet, B. K. (2001) · Biochemistry · doi:10.1021/bi0109358 · Cited by 115
Benkovic, S. J., Baker, S. J., Alley, M. R. K., Woo, Y., Zhang, Y.-K., Akama, T., Mao, W., Baboval, J., Rajagopalan, P. T. R., Wall, M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050676a · Cited by 115
Structural Milestones in the Reaction Pathway of an Amide Hydrolase
Beadle, B. M., Trehan, I., Focia, P. J., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00725-6 · Cited by 112
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 112
OKAZAKI, T., KITAHARA, T., & Okami, Y. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.176 · Cited by 112
Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV
Balzarini, J. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70271-1 · Cited by 102
Williams, S. A., & McConkey, D. J. (2003) · PubMed · Cited by 99
Baker, S. J., Akama, T., Zhang, Y.-K., Sauro, V., Pandit, C., Singh, R., Kully, M. L., Khan, J., Plattner, J. J., Benkovic, S. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.130 · Cited by 94
α‐Amido boronic acids: A synthetic challenge and their properties as serine protease inhibitors
Matteson, D. S. (2007) · Medicinal Research Reviews · doi:10.1002/med.20105 · Cited by 93
Boromycin, an Anti-HIV Antibiotic
Kohno, J., Kawahata, T., Otake, T., Morimoto, M., Mori, H., Noboru, U. E. B. A., NISHIO, M., Kinumaki, A., Komatsubara, S., & Kawashima, K. (1996) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60.1036 · Cited by 93
p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells
MacLaren, A., Chapman, R. S., Wyllie, A. H., & Watson, C. J. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400801 · Cited by 91
Strategies for the inhibition of serine proteases
Walker, B., & Lynas, J. F. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000884 · Cited by 89
Energetic, structural, and antimicrobial analyses of β-lactam side chain recognition by β-lactamases
Caselli, E., Powers, R. A., Blasczcak, L. C., Wu, C. Y. E., Prati, F., & Shoichet, B. K. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00052-1 · Cited by 87
Asai, A., Tsujita, T., Sharma, S. V., Yamashita, Y., Akinaga, S., Funakoshi, M., Kobayashi, H., & Mizukami, T. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.035 · Cited by 86
Nicola, G., Peddi, S., Stefanova, M. E., Nicholas, R. A., Gutheil, W. G., & Davies, C. (2005) · Biochemistry · doi:10.1021/bi0473004 · Cited by 84
New ligands for boronte affinity chromatography
Singhal, R. P., Ramamurhy, B., Govindraj, N., & Sarwar, Y. (1991) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)95752-8 · Cited by 82
Design, Synthesis, and Biological Activity of Boronic Acid-Based Histone Deacetylase Inhibitors
Suzuki, N., Suzuki, T., Ota, Y., Nakano, T., Kurihara, M., Okuda, H., Yamori, T., Tsumoto, H., Nakagawa, H., & Miyata, N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900125m · Cited by 82
Structure-Based Discovery of a Boronic Acid Bioisostere of Combretastatin A-4
Kong, Y., Grembecka, J. E., Edler, M., Hamel, E., Mooberry, S. L., Sabat, M., Rieger, J. M., & Brown, M. L. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.06.016 · Cited by 81
Connolly, B. A., Sanford, D. G., Chiluwal, A. K., Healey, S. E., Peters, D. E., DiMare, M. T., Wu, W., Liu, Y., Maw, H. H., Zhou, Y., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800390n · Cited by 76
Zhu, Y., Zhao, X., Zhu, X., Wu, G., Li, Y., Ma, Y., Yuan, Y., Yang, J., Hu, Y., Ai, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9005093 · Cited by 75
LeBeau, A. M., Singh, P., Isaacs, J. T., & Denmeade, S. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.05.020 · Cited by 67
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Shimizu, K., Maruyama, M., Yasui, Y., Minegishi, H., Ban, H. S., & Nakamura, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.037 · Cited by 66
Jay, J. I., Lai, B. E., Myszka, D. G., Mahalingam, A., Langheinrich, K., Katz, D. F., & Kiser, P. F. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900159n · Cited by 65
Discovery of Boronic Acids as Novel and Potent Inhibitors of Fatty Acid Amide Hydrolase
Minkkilä, A., Saario, S. M., Käsnänen, H., Leppänen, J., Poso, A., & Nevalainen, T. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801051t · Cited by 65
Induction of intestinal glucose carriers in streptozocin-treated chronically diabetic rats
Fedorak, R. N., Gershon, M. D., & Field, M. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90761-0 · Cited by 61
Liu, J., & Tsai, M. (2001) · Biochemistry · doi:10.1021/bi010646j · Cited by 57
Elucidation of enzyme mechanisms using fluorinated substrate analogues
Pongdee, R., & Liu, H. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.06.012 · Cited by 54
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy
Venturelli, A., Tondi, D., Cancian, L., Morandi, F., Cannazza, G., Segatore, B., Prati, F., Amicosante, G., Shoichet, B. K., & Costi, M. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070643q · Cited by 45
Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase
Ban, H. S., Usui, T., Nabeyama, W., Morita, H., Fukuzawa, K., & Nakamura, H. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b909504g · Cited by 45
Boronic acids as inhibitors of steroid sulfatase
Ahmed, V. F., Liu, Y., Silvestro, C., & Taylor, S. D. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.033 · Cited by 45
Inglis, S. R., Zervosen, A., Woon, E. C. Y., Gerards, T., Teller, N., Fischer, D. S., Luxen, A., & Schofield, C. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9009718 · Cited by 45
Zhu, Y., Zhu, X., Wu, G., Ma, Y., Li, Y., Zhao, X., Yuan, Y., Yang, J., Yu, S., Shao, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901407s · Cited by 39
Overexpression and enzymatic characterization of Neisseria gonorrhoeae penicillin‐binding protein 4
Stefanova, M. E., Tomberg, J., Davies, C., Nicholas, R. A., & Gutheil, W. G. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03886.x · Cited by 38
Potent inhibitors of HCV-NS3 protease derived from boronic acids
Venkatraman, S., Wu, W., Prongay, A., GIRIJAVALLABHAN, V. M., & Njoroge, F. G. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.124 · Cited by 36
Winum, J., Innocenti, A., Scozzafava, A., Montero, J., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.03.058 · Cited by 35
Role of Asp104 in the SHV β-Lactamase
Bethel, C. R., Hujer, A. M., Hujer, K. M., Thomson, J. M., Ruszczycky, M. W., Anderson, V. E., Pusztai‐Carey, M., Taracila, M. A., Helfand, M. S., & Bonomo, R. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00848-06 · Cited by 34
Zhu, Y., Lei, M., Lu, A., Zhao, X., Yin, X.-J., & Gao, Q. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.07.019 · Cited by 33
Synthesis of boronic acid derivatives of tyropeptin: Proteasome inhibitors
Watanabe, T., Momose, I., Abe, M., Abe, H., Sawa, R., Umezawa, Y., Ikeda, D., Takahashi, Y., & Akamatsu, Y. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.117 · Cited by 26
Nakamura, H., Watanabe, M., Ban, H. S., Nabeyama, W., & Asai, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.103 · Cited by 24
Thomson, J. M., Prati, F., Bethel, C. R., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01293-06 · Cited by 16
Cited by
Photoinduced decarboxylative borylation of carboxylic acids
Fawcett, A., Pradeilles, J., Wang, Y., Mutsuga, T., Myers, E. L., & Aggarwal, V. K. (2017) · Science · doi:10.1126/science.aan3679 · Cited by 702
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Self-citationZhang, Z. P., Rong, M. Z., & Zhang, M. Q. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.03.002 · Cited by 586
Biomedical applications of boronic acid polymers
Cambre, J. N., & Sumerlin, B. S. (2011) · Polymer · doi:10.1016/j.polymer.2011.07.057 · Cited by 435
Li, C., Wang, J., Barton, L. M., Yu, S., Tian, M., Peters, D. S., Kumar, M., Yu, A. W., Johnson, K. A., Chatterjee, A. K., et al. (2017) · Science · doi:10.1126/science.aam7355 · Cited by 379
Metadata
- Authors
- Trippier, P. C., & McGuigan, C.
- Venue
- MedChemComm
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2010
- Volume
- 1
- Issue
- 3
- Pages
- 183
- ISSN
- 2040-2503 (ISSN-L)
- 2040-2511
- OpenAlex
- W2008470810
- Cited by
- 346
- References
- 80
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.